Identification of PEDV inhibitors targeting 3CL protease
Authors:
Open Access
- 1 June 2025
- journal article
- Published by KEAI Publishing in Virologica Sinica
- Vol. 40 (4) , 624-635
Abstract
Porcine epidemic diarrhea (PED), caused by porcine epidemic diarrhea virus (PEDV), is a highly contagious gastrointestinal disease characterized by vomiting, diarrhea, and dehydration, with mortality rates approaching 100% among suckling piglets. The PEDV 3C-like protease (3CLpro) is essential for viral replication and regarded as a critical target for antiviral inhibitor development. In this study, we aimed to identify small-molecule inhibitors of PEDV by targeting 3CLpro. Virtual screening of 1.6 million compounds from the ChemDiv library identified four potential candidates. Molecular dynamics simulations, (RMSD, RMSF, Rg) revealed enhanced structural stability of the compound-protease complexes compared to the monomeric enzyme. All compounds had low cytotoxicity in Vero cells (CC50 > 200 μM). Fluorescence resonance energy transfer-based assays demonstrated dose-dependent inhibitory activity of the compounds against 3CLpro. Among the candidates, compound F366-0161 exhibited the weakest inhibition, with an IC50 value of 151.5 μM. Two analogues, 3238-0395 (IC50 of 121.4 μM) and L878-0493 (IC50 of 123.6 μM), exhibited moderately enhanced activity. Y041-1672 was identified as the most effective inhibitor, with an IC50 of 86.48 μM. In viral replication inhibition assays, Y041-1672 reduced PEDV replication, with an EC50 of 17.97 μM and a selectivity index (SI) of 15.5 (CC50/EC50). These results were validated by RT-qPCR, plaque assays, immunofluorescence, and Western blot analyses. In vitro validation confirmed Y041-1672 as the optimal antiviral candidate, and time-of-addition experiments indicated that inhibition primarily occurred during viral replication. This study identifies scaffold molecules for PEDV antiviral drug development, providing strategic insights for PED treatment.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFD1800303)
- National Natural Science Foundation of China (32473044)
This publication has 41 references indexed in Scilit:
- Octyl gallate targeting the 3C-like protease exhibits highly efficient antiviral activity against swine enteric coronavirus PEDVVeterinary Microbiology, 2023
- Identification of a small compound that specifically inhibits Zika virus in vitro and in vivo by targeting the NS2B-NS3 proteaseAntiviral Research, 2022
- Inhibition of the SARS-CoV-2 3CLpro main protease by plant polyphenolsFood Chemistry, 2021
- Arylethynyl Helices Supported by π‐Stacking and Halogen BondingChempluschem, 2021
- Porcine epidemic diarrhea virus infection: Etiology, epidemiology, pathogenesis and immunoprophylaxisThe Veterinary Journal, 2015
- Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infectionHepatology, 2014
- CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR dataJournal of Computational Chemistry, 2013
- CHARMM: The biomolecular simulation programJournal of Computational Chemistry, 2009
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005